National Vaccine and Serum Institute, China

Works in Infectious disease · Renal & urogenital · Respiratory

National Vaccine and Serum Institute, China is a clinical trial sponsor. It has 2 active clinical trials with 15,300 planned participants, in Infectious disease, Renal & urogenital and Respiratory. Since 2021 it has completed 6 trials and stopped 0 early.

Trial track record · since 2021

2Active trials15,300 planned participants
6Completed0 with results posted
0Stopped early0% of finished trials

Pipeline · 2 active trials

StageTrialStatus

Questions about National Vaccine and Serum Institute, China

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-28.

Approve Suite is not affiliated with National Vaccine and Serum Institute, China.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.